International Life & Health Industry Equity Investment Competition Opens for Applications

The Beijing leg of the inaugural International Equity Investment Competition for the Life and Health Industry will be held on September 28 at the Grand Skylight International Hotel in Beijing. The event is hosted by the Wuxi Xidong New City Business District, organized by Jiangsu Bole Health Industry Management Service Co., Ltd. (hereinafter referred to as “Bole Industrial Services Group”), a subsidiary of HighLight Capital’s Industrial Services Group. Distinguished guests include leading investment institutions such as HighLight Capital, Cathay Innovation, and Saiying Capital, as well as Medisino Group, a comprehensive service provider specializing in R&D, manufacturing, and regulatory consulting for medical devices. VCBeat serves as the invited media partner, providing full-scale support for the competition.

Amid the COVID-19 pandemic, the global health industry chain and medical technology innovation and development have entered a new phase. According to the “Healthy China 2030” Planning Outline issued by the Central Committee of the Communist Party of China and the State Council, China’s health service industry is expected to reach a market size of RMB 8 trillion in 2020 and RMB 16 trillion by 2030. Guided by policy directions and market demand, the prospects for the healthcare industry are becoming increasingly clear.

To further align with national policies and support the development and innovation of the global life and health industry, this competition focuses on high-quality innovation and entrepreneurship projects from domestic and international medical institutions, universities and research institutes, physician groups, and other entities. The products involved cover niche sectors such as medical devices, biopharmaceuticals, and health consumer goods.

The judging panel comprises seasoned experts from leading venture capital firms, who will evaluate submissions across multiple dimensions, including product innovation and clinical and market application prospects. The awards are divided into two categories: the “Qianlima Award” and the “Bole Award.” Projects honored with the “Qianlima Award” will have the opportunity to secure signing and implementation agreements, receive equity investments of up to tens of millions of yuan, benefit from preferential policy channels, and enjoy comprehensive promotional support throughout the process.

According to the competition organizers, many high-quality medical projects in China have secured financing but encountered obstacles during the registration and approval phase prior to product launch. Therefore, unlike traditional roadshows, this competition not only coordinates with entities such as the Wuxi Xidong New City Business District to provide policy support, but also specially invites Medthink, a third-party regulatory consulting service platform, to offer technical guidance to participating projects, thereby facilitating the rapid commercialization and translation of their products. In addition, public service platforms under the Bole Industrial Services Group, including its Wuxi incubator and the Wuxi International Life Health Smart Park, can provide office and production space to empower participating enterprises.

Beijing serves as the inaugural host city for the International Life and Health Industry Equity Investment Competition, which will subsequently be held in Shanghai, Shenzhen, and Wuxi. We look forward to greater participation from high-quality projects within the health industry, working together to drive the sector’s healthy and rapid development.

Scan the QR code to register and receive a coffee gift box on-site.

Official Event Website: http://ilheic.com/